Loomis Sayles & Co. L P Buys Shares of 522,109 Astrana Health, Inc. (NASDAQ:ASTH)

Loomis Sayles & Co. L P purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 522,109 shares of the company’s stock, valued at approximately $30,251,000. Loomis Sayles & Co. L P owned about 1.06% of Astrana Health at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. GAMMA Investing LLC purchased a new position in shares of Astrana Health during the 3rd quarter worth approximately $34,000. Nisa Investment Advisors LLC acquired a new stake in shares of Astrana Health in the third quarter valued at $35,000. KBC Group NV purchased a new stake in shares of Astrana Health in the 3rd quarter valued at $70,000. Quest Partners LLC acquired a new position in Astrana Health during the 3rd quarter worth about $133,000. Finally, Central Pacific Bank Trust Division purchased a new position in Astrana Health during the 3rd quarter valued at about $160,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. BTIG Research boosted their price target on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Truist Financial lifted their target price on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a report on Friday, August 9th. Robert W. Baird upped their price target on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Stifel Nicolaus boosted their price objective on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Finally, KeyCorp initiated coverage on shares of Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $65.17.

Astrana Health Price Performance

Shares of ASTH opened at $42.40 on Tuesday. The firm has a fifty day moving average price of $54.17 and a 200 day moving average price of $47.94. The stock has a market cap of $2.39 billion, a PE ratio of 32.62, a price-to-earnings-growth ratio of 1.95 and a beta of 1.24. Astrana Health, Inc. has a 1-year low of $32.32 and a 1-year high of $63.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. During the same period in the prior year, the firm earned $0.47 EPS. As a group, sell-side analysts anticipate that Astrana Health, Inc. will post 1.17 EPS for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.